Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
19%
ALSO IN BBP
BBP
57
HOLDINGS
16%
ALSO IN CANC
SECTOR DRIFT (CANC minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 4.4% | 3.2% | 3.2% |
|
BEIGENE LTD. SPONSORED ADR | 2.2% | 2.9% | 2.2% |
|
GILEAD SCIENCES INC | 2.0% | 2.1% | 2.0% |
|
EXELIXIS INC | 3.1% | 1.8% | 1.8% |
|
AMGEN INC | 2.2% | 1.7% | 1.7% |
CANC Overweight Relative to BBP
|
REVOLUTION MEDICINES, INC. | 6.3% |
|
ELI LILLY & CO | 5.1% |
 |
ASTRAZENECA PLC | 4.3% |
 |
NOVARTIS AG | 4.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
COGENT BIOSCIENCES INC | 3.9% |
 |
GENMAB A/S SPONSORED ADR | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 3.4% |
|
NUVALENT, INC. CLASS A | 3.3% |
|
JOHNSON & JOHNSON | 3.2% |
CANC Underweight Relative to BBP
|
INSMED INC | -3.3% |
|
ALNYLAM PHARMACEUTICALS INC | -3.0% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -3.0% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |